Eric Schadt is founder and CEO of Sema4, a predictive health company creating tools to better diagnose, treat, and prevent disease. He is dean for precision medicine at Mount Sinai Icahn School of Medicine, where he was previously founding director of the Icahn Institute for Genomics and Multiscale Biology and professor and chair of the Genetics and Genomic Sciences Department. An expert on constructing predictive models of disease that link molecular biology to physiology, Schadt has built groups and companies (including Merck, Rosetta, Sage Bionetworks, and Pacific Biosciences) to address the complexity of human diseases and contributed to discoveries on the genetic basis of common human diseases like diabetes and obesity.
Previously
The technology for analyzing the genetic code of animals, including humans, has grown more sophisticated even as its cost has fallen dramatically. Increasingly, we can do a lo...